Analyst Keith Bachman of BMO Capital maintained a Hold rating on Genpact (G – Research Report), with a price target of $58.00.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Keith Bachman has given his Hold rating due to a combination of factors, including Genpact’s impressive financial performance in the recent quarter and its guidance for future growth. The company demonstrated strong revenue growth, particularly in the Data-Tech-AI sector, which exceeded expectations. This growth was coupled with solid operating margins and an optimistic forecast for FY25.
Despite these positive indicators, Bachman expressed concerns about the sustainability of Genpact’s growth in the long term, particularly considering the potential impact of generative AI. While the company’s short-term outlook appears robust, the uncertainty surrounding future market conditions and the visibility into the Data-Tech-AI segment led to a cautious stance. Consequently, the Hold rating reflects both the strengths observed in recent performance and the uncertainties regarding future growth prospects.
In another report released yesterday, Mizuho Securities also reiterated a Hold rating on the stock with a $45.00 price target.
Based on the recent corporate insider activity of 44 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of G in relation to earlier this year.